BeyondSpring is trading 7.28% up now at $0.66, alongside a 2.75% gain across the biotech sector.
- No company-specific announcement, filing, earnings release, or analyst action dated September 3, 2026, was identified.
- The latest listed updates are older clinical and corporate announcements, including July 2026 news activity.
- The move therefore appears primarily sector-driven rather than linked to a fresh BeyondSpring catalyst.